当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析

浙江医药

(600216)

  

流通市值:138.57亿  总市值:138.57亿
流通股本:9.62亿   总股本:9.62亿

浙江医药(600216)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润3.85亿元,每股收益0.43元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1126596.63万元,未分配利润634230.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1399665.34万元,负债273068.71万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入2,255,389,182.259,375,216,922.057,112,804,346.34,405,467,286.37
营业总成本1,778,067,510.037,934,024,498.036,103,341,032.994,013,409,994.55
营业利润454,250,358.651,223,110,445.3937,076,246.21341,433,350.41
利润总额453,782,461.451,212,282,187.41930,805,265.38334,589,302.43
净利润385,252,415.31,020,251,510.18758,558,082.68255,365,468.01
其他综合收益9,122,458.68-7,635,393.08-1,441,540.27-4,263,504.68
综合收益总额394,374,873.981,012,616,117.1757,116,542.41251,101,963.33
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计6,811,951,484.566,584,941,036.576,146,702,104.365,669,917,652.8
非流动资产合计7,184,701,913.077,210,532,069.127,282,810,008.957,207,961,635.47
资产总计13,996,653,397.6313,795,473,105.6913,429,512,113.3112,877,879,288.27
流动负债合计2,386,933,768.282,569,444,450.432,358,145,040.772,129,820,180.22
非流动负债合计343,753,324.51358,086,415.36461,965,749.34503,302,563.07
负债合计2,730,687,092.792,927,530,865.792,820,110,790.112,633,122,743.29
归属于母公司股东权益合计11,067,801,751.7210,648,142,085.0610,341,301,291.019,946,975,299.51
股东权益合计11,265,966,304.8410,867,942,239.910,609,401,323.210,244,756,544.98
负债和股东权益合计13,996,653,397.6313,795,473,105.6913,429,512,113.3112,877,879,288.27
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计2,410,514,065.329,130,924,502.026,962,388,408.794,326,020,955.81
经营活动现金流出小计2,105,549,414.327,907,625,860.076,270,328,271.844,116,632,777.24
经营活动产生的现金流量净额304,964,6511,223,298,641.95692,060,136.95209,388,178.57
投资活动现金流入小计472,919,982.851,211,707,968.83949,820,843.47690,902,928.02
投资活动现金流出小计591,343,225.751,685,207,838.411,233,043,731.02858,562,907.49
投资活动产生的现金流量净额-118,423,242.9-473,499,869.58-283,222,887.55-167,659,979.47
筹资活动现金流入小计185,000,000520,000,000485,000,000485,000,000
筹资活动现金流出小计142,771,240.27775,320,876.26732,293,731.81529,803,646.59
筹资活动产生的现金流量净额42,228,759.73-255,320,876.26-247,293,731.81-44,803,646.59
汇率变动对现金及现金等价物的影响22,827,650.8311,267,874.7614,146,462.7811,891,286.53
现金及现金等价物净增加额251,597,818.66505,745,770.87175,689,980.378,815,839.04
期末现金及现金等价物余额2,217,183,229.721,965,585,411.061,635,529,620.561,468,655,479.23
最新报告期:2025-05-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券王彤,肖亚平1.361.551.702025-05-06
光大证券蔡嘉豪,赵乃迪1.481.681.922025-04-27
中金公司侯一林,裘孝锋,贾雄伟1.141.14--2025-04-23
TOP↑